<?xml version="1.0" encoding="UTF-8"?>
<p class="p">EFEN had better pharmacokinetic behavior than EA alone. The higher bioavailability was related to higher absorption, higher concentration over time, and lower clearance. The superior pharmacokinetic properties of EFEN definitely favored the production of therapeutic effects (Zhou etÂ al., 
 <xref rid="CIT0033" ref-type="bibr" class="xref">2016</xref>). EFEN could be maintained in the tumor area via injection.
</p>
